GlassScriptPhysician profile
Catherine Wintle
NPI 1801981881
$557.53
in general payments reported to CMS, 2019-2025
9 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.25 · 2022: $92.55 · 2023: $91.04 · 2024: $126 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $129.40 | 2025 | |
| Pfizer INC. | $113.12 | 2022-2025 | |
| Glaxosmithkline, LLC. | $106.48 | 2021-2024 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $79.01 | 2021-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $39.12 | 2022-2023 | Freestyle Libre 2 |
| Abbvie INC. | $33.28 | 2025 | |
| Dynavax Technologies Corporation | $26.02 | 2024 | Heplisav-B |
| Daiichi Sankyo INC. | $15.66 | 2024 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $15.44 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Wintle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.